Pharmacokinetics and efficacy of tank-water administered BRAF-inhibitor dabrafenib in a zebrafish model of BRAF-mutant melanoma
Jenna Villman(University of Turku), Kari J. Kurppa(Åbo Akademi University)
Cited by 0
Related Papers
Recurrent cancer‐associated <scp>ERBB4</scp> mutations are transforming and confer resistance to targeted therapies
|Molecular Oncology|2025|0
YAP/TEAD drives treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer
|bioRxiv (Cold Spring Harbor Laboratory)|2026|0